For example, Sostoa et al. [54] used a FAP-targeting bispecific T cell engager (FBiTE) to carry oncolytic adenovirus (OAd), which can not only enhance the lytic effect of the virus on tumor cells but also increase the cytotoxic effect mediated by FBiTE on FAP-expressing CAFs. Here, FAP is linked to neoplasm.